β-Cell Glucose Non-sensing in Patients with Thalassemia major and Glucose Intolerance

  • G. Petrou
  • M. Makri
  • A. Armoni
  • B. E. Spiliotis
  • T. K. Alexandrides


Diabetes mellitus (DM), a relatively frequent complication in patients with thalassemia major (β-thal), is usually attributed to insulin deficiency due to islet β-cell loss because of toxic effects of iron deposited in the pancreatic islets [1–4]. There is also evidence for insulin resistance in peripheral tissues that precedes the development of diabetes [5–8]. A prospective long-term study of ours (6 years) of 60 patients with β-thal (unpublished data) agrees with previous data in the literature [8] showing that insulin resistance becomes evident in the pubertal period and progressively increases with age. Since in type-I and type-II DM the earliest finding in the prediabetic state is the diminished first-phase response of insulin to glucose infusion (IVGTT), while the insulin response to i.v. arginine, i.v. glucagon, oral glucose tolerance (OGTT) and i.v. tolbutamide is preserved or slightly impaired, this has been interpreted as decreased β-cell glucose non-sensing [9]. The purpose of this study was to investigate the possibility that there is also β-cell glucose nonsensing in the prediabetic state in β-thal.


Insulin Response Thalassemia Major Prediabetic State Cell Glucose Pubertal Period 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lassman MN, Genel M, Wise JK, Hendler R, Felig P (1974) Carbohydrate homeostasis and pancreatic islet cell function in thalassemia. Ann Intern Med 80: 65–69PubMedGoogle Scholar
  2. 2.
    Mcintosh N (1976) Endocrinopathy in thalassemia major. Arch Dis child 51: 195–201PubMedCrossRefGoogle Scholar
  3. 3.
    Saudek CD, Hemm RM, Peterson CM (1977) Abnormal glucose tolerance in β-thalassemia major. Metabolism 26: 43–52PubMedCrossRefGoogle Scholar
  4. 4.
    Zuppinger K, Molinari B, Hirt A et al. (1979) Increased risk of diabetes mellitus in beta-thalassemia major due to iron overload. Helv Paediatr Acta 34: 197–207PubMedGoogle Scholar
  5. 5.
    Flynn DM, Fairney A, Jackson D, Clayton BE (1976) Hormonal changes in thalassemia major. Arch Dis Child 51: 828–836PubMedCrossRefGoogle Scholar
  6. 6.
    Costin G, Kogut MD, Hyman C, Ortega JA (1977) Carbohydrate metabolism and pancreatic isletcell function in thalassemia major. Diabetes 26: 230–240PubMedCrossRefGoogle Scholar
  7. 7.
    Dandona P, Hussain MAM, Varghese Z, Politis D, Flynn DM, Hoffbrand AV (1983) Insulin resistance and iron overload. Ann Clin Biochem 20: 77–79PubMedGoogle Scholar
  8. 8.
    Merkel PA, Simonson DC, Amiel SA et al. (1988) Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 318: 809–814PubMedCrossRefGoogle Scholar
  9. 9.
    Ganda OP, Srikanta S, Brink SJ et al. (1984) Differential sensitivity to β-cell secretagogues in “early” type-I diabetes mellitus. Diabetes 33: 516–521PubMedCrossRefGoogle Scholar
  10. 10.
    Brunzell JD, Robertson RP, Lerner RL et al. (1979) Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42: 222–229CrossRefGoogle Scholar
  11. 11.
    Robertson RP (1989) Type-II diabetes, glucose “non-sense”, and islet desensitization. Diabetes 38: 1501–1505PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • G. Petrou
  • M. Makri
  • A. Armoni
  • B. E. Spiliotis
  • T. K. Alexandrides

There are no affiliations available

Personalised recommendations